Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0440
+0.0010 (2.33%)
Jun 17, 2026, 11:57 AM AEST
Resonance Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 13.84 | 11.07 | 8.59 | 4.4 | 3.83 | 3.78 |
Other Revenue | - | - | - | - | 0.03 | - |
| 13.84 | 11.07 | 8.59 | 4.4 | 3.85 | 3.78 | |
Revenue Growth (YoY) | 31.36% | 28.91% | 95.02% | 14.31% | 1.96% | 3.02% |
Gross Profit | 13.84 | 11.07 | 8.59 | 4.4 | 3.85 | 3.78 |
Selling, General & Admin | 10.32 | 9.88 | 7.37 | 4.19 | 3.76 | 2.38 |
Research & Development | 0.7 | 0.96 | 0.84 | 0.71 | 0.72 | 0.39 |
Amortization of Goodwill & Intangibles | 0.5 | 0.52 | 0.26 | 0.3 | 0.31 | 0.29 |
Other Operating Expenses | 0.99 | 0.85 | 0.42 | 0.43 | 0.47 | 0.24 |
Operating Expenses | 12.9 | 12.66 | 9.12 | 5.76 | 5.38 | 3.38 |
Operating Income | 0.94 | -1.58 | -0.53 | -1.36 | -1.52 | 0.4 |
Interest Expense | -0.33 | -0.32 | -0.05 | - | - | - |
Interest & Investment Income | 0.02 | 0.04 | 0.14 | 0.04 | 0 | 0.04 |
Currency Exchange Gain (Loss) | -0.07 | 0.04 | 0.04 | 0.29 | 0.19 | -0.09 |
Other Non Operating Income (Expenses) | -0.26 | -0.3 | -0.23 | -0.2 | -0.22 | -0.01 |
EBT Excluding Unusual Items | 0.29 | -2.12 | -0.63 | -1.23 | -1.55 | 0.34 |
Gain (Loss) on Sale of Assets | -0.08 | -0.08 | - | - | - | - |
Asset Writedown | - | - | - | -0.03 | - | - |
Pretax Income | 0.22 | -2.2 | -0.63 | -1.26 | -1.55 | 0.34 |
Income Tax Expense | -0.55 | -0.47 | -0.8 | -0.48 | -0.41 | -0.24 |
Net Income | 0.77 | -1.73 | 0.17 | -0.78 | -1.14 | 0.59 |
Net Income to Common | 0.77 | -1.73 | 0.17 | -0.78 | -1.14 | 0.59 |
Shares Outstanding (Basic) | 467 | 455 | 456 | 461 | 461 | 450 |
Shares Outstanding (Diluted) | 474 | 455 | 468 | 461 | 461 | 452 |
Shares Change (YoY) | 5.65% | -2.81% | 1.59% | - | 1.97% | 4.59% |
EPS (Basic) | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 |
EPS (Diluted) | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 |
Free Cash Flow | 0.05 | 0.81 | 1.16 | -0.45 | -1.57 | 1.13 |
Free Cash Flow Per Share | - | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 6.77% | -14.30% | -6.16% | -30.89% | -39.57% | 10.58% |
Profit Margin | 5.56% | -15.65% | 1.97% | -17.72% | -29.63% | 15.50% |
Free Cash Flow Margin | 0.34% | 7.27% | 13.48% | -10.11% | -40.86% | 29.86% |
EBITDA | 1.12 | -1.41 | -0.41 | -1.32 | -1.49 | 0.42 |
EBITDA Margin | 8.09% | -12.72% | -4.77% | -29.96% | -38.69% | 11.09% |
D&A For EBITDA | 0.18 | 0.18 | 0.12 | 0.04 | 0.03 | 0.02 |
EBIT | 0.94 | -1.58 | -0.53 | -1.36 | -1.52 | 0.4 |
EBIT Margin | 6.77% | -14.30% | -6.16% | -30.89% | -39.57% | 10.58% |